Effectiveness, Tolerability, Safety of Rasagiline in Early Parkinson's Disease Patients Without Levodopa

Study Title

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Teva Identifier

TVP-1012/232

ClinicalTrials.gov Identifier

NCT00203060

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: Rasagiline Mesylate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

35 Years and older

Trial Duration

07/01/1997 - 07/01/2000

Phase

Phase 3

Study Type

Interventional